Sarrah Ayuandari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sarrah Ayuandari has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Agung Dewanto
Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publicationsKuky Cahya Hamurajib
Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publicationsNaafi Rizqi Rahmawati
Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publicationsNurulita Ainun Alma
Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publicationsRizki Oktasari
Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publicationsSri Mulatsih
Department of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications
Latest Publications
- 21 May 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 33 (7) , 1803-1812
The difference in collagen type-1 expression in women with and without pelvic organ prolapse: a systematic review and meta-analysis
Introduction and hypothesis This study was aimed at identifying the difference in collagen type-1 expression in women with and without pelvic organ prolapse (POP). Methods A systematic review and meta-analysis was carried out women with and without pelvic organ prolapse. This meta-analysis was conducted on research articles describing the evaluation of collagen type-1 expression between patients with and without POP. The articles were obtained from PubMed, EBSCO, and ProQuest, and were published between January 2000 and June 2021. Pooled mean difference (MD) and pooled odds ratio (OR) were calculated using fixed effect models. Review Manager (RevMan 5.4) was used to analyze the data. The main outcome measures were pooled MD and pooled OR of collagen type-1 expression in patients with and without POP. Results A total of seven case–control studies were included in the meta-analysis using the effect size of the MD and two case–control studies were included in the meta-analysis using the effect size of the OR. A total of 247 POP cases and 132 non-POP cases were identified from the studies. Our study indicated that patients with POP had a lower level of collagen type-1 expression than non-POP patients (MD = −6.77; 95% CI: −8.37, −5.17, p < 0.00001). Patients with low expression of collagen type-1 in pelvic support tissue are at a more than 3 times higher risk of suffering from pelvic organ prolapse (OR = 3.23, 95% CI: 1.52 to 6.87, p = 0.002). Conclusion The results of this study showed that patients with pelvic organ prolapse have lower expression of collagen type-1 than nonpelvic organ prolapse patients.
- 21 May 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 33 (7) , 1803-1812
The difference in collagen type-1 expression in women with and without pelvic organ prolapse: a systematic review and meta-analysis
Introduction and hypothesis This study was aimed at identifying the difference in collagen type-1 expression in women with and without pelvic organ prolapse (POP). Methods A systematic review and meta-analysis was carried out women with and without pelvic organ prolapse. This meta-analysis was conducted on research articles describing the evaluation of collagen type-1 expression between patients with and without POP. The articles were obtained from PubMed, EBSCO, and ProQuest, and were published between January 2000 and June 2021. Pooled mean difference (MD) and pooled odds ratio (OR) were calculated using fixed effect models. Review Manager (RevMan 5.4) was used to analyze the data. The main outcome measures were pooled MD and pooled OR of collagen type-1 expression in patients with and without POP. Results A total of seven case–control studies were included in the meta-analysis using the effect size of the MD and two case–control studies were included in the meta-analysis using the effect size of the OR. A total of 247 POP cases and 132 non-POP cases were identified from the studies. Our study indicated that patients with POP had a lower level of collagen type-1 expression than non-POP patients (MD = −6.77; 95% CI: −8.37, −5.17, p < 0.00001). Patients with low expression of collagen type-1 in pelvic support tissue are at a more than 3 times higher risk of suffering from pelvic organ prolapse (OR = 3.23, 95% CI: 1.52 to 6.87, p = 0.002). Conclusion The results of this study showed that patients with pelvic organ prolapse have lower expression of collagen type-1 than nonpelvic organ prolapse patients.
- 19 January 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 305 (6) , 1581-1586
Anti-Mullerian hormone and puberty development in girls and adolescents who underwent cancer treatment
Background High survival rates of children diagnosed with cancer have led to a growing population of women with premature ovarian failure (POF) due to chemotherapy and radiotherapy. The POF process occurs due to the disruption of the hypothalamic–pituitary and gonadal axis followed by the delay of puberty development. Evaluation of reproductive function in children with cancer is essential to determine the fertility preservation plan. This study aimed to describe reproductive functions in children and adolescents with cancer who received chemotherapy based on Tanner stage evaluation, menstrual cycle, and anti-Mullerian hormone (AMH) examination using electro-chemiluminescence immunoassay kit. Results Twenty-three girls aged 12–18 years old and had menarche who underwent cancer therapy in January–August 2019 in Dr. Sardjito General Hospital were included in the study. Among them, 61% had low AMH levels and were defined as diminished ovarian reserve (DOR). Two subjects with DOR experienced delayed puberty. Regular menstrual cycle was reported in 65.2% of subjects and irregular menstrual cycle in 34.8%, while 21.7% with irregular menstrual cycle encountered secondary amenorrhea. Conclusion Chemotherapy exposure affected DOR occurrence in 60.9% of patients with childhood and adolescence cancer. Moreover, it also altered menstrual regularity in 34.8% and delayed puberty development in 8.7% subjects.
- 19 January 2022
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 305 (6) , 1581-1586
Anti-Mullerian hormone and puberty development in girls and adolescents who underwent cancer treatment
Background High survival rates of children diagnosed with cancer have led to a growing population of women with premature ovarian failure (POF) due to chemotherapy and radiotherapy. The POF process occurs due to the disruption of the hypothalamic–pituitary and gonadal axis followed by the delay of puberty development. Evaluation of reproductive function in children with cancer is essential to determine the fertility preservation plan. This study aimed to describe reproductive functions in children and adolescents with cancer who received chemotherapy based on Tanner stage evaluation, menstrual cycle, and anti-Mullerian hormone (AMH) examination using electro-chemiluminescence immunoassay kit. Results Twenty-three girls aged 12–18 years old and had menarche who underwent cancer therapy in January–August 2019 in Dr. Sardjito General Hospital were included in the study. Among them, 61% had low AMH levels and were defined as diminished ovarian reserve (DOR). Two subjects with DOR experienced delayed puberty. Regular menstrual cycle was reported in 65.2% of subjects and irregular menstrual cycle in 34.8%, while 21.7% with irregular menstrual cycle encountered secondary amenorrhea. Conclusion Chemotherapy exposure affected DOR occurrence in 60.9% of patients with childhood and adolescence cancer. Moreover, it also altered menstrual regularity in 34.8% and delayed puberty development in 8.7% subjects.
- Open Access
- 21 July 2021
- Published by Springer Nature in Research Square
Anti-Mullerian Hormone And Puberty Development On Girls And Adolescents Who Underwent Cancer Treatment
Background: High survival rate of children diagnosed with cancer has led to a growing population of women with premature ovarian failure (POF) due to chemotherapy and radiotherapy. The POF process occurs due to the disruption of the Hypothalamic-Pituitary and gonadal axis followed by the delay of puberty development. Evaluation of reproductive function in children with cancer is essential to determine the fertility preservation plan. This study aimed to describe reproductive function in children and adolescents with cancer who received chemotherapy based on Tanner stage evaluation, menstrual cycle, and Anti-Mullerian Hormone (AMH) examination using Electrochemilumiscence Immunoassay (ECLIA) Kit.Result: Twenty-three girls aged 12-18 years old and had menarche who underwent cancer therapy in January-August 2019 in Dr. Sardjito General Hospital were included in the study. Among them, 61% girls had low AMH levels and were defined as Diminished Ovarian Reserve (DOR). There were two subjects with DOR who experienced delayed puberty. Regular menstrual cycle was reported in 65.2% subjects, while 21.7% encountered secondary amenorrhea.Conclusion: Chemotherapy exposure impacted on DOR occurrence in 60.9% childhood and adolescence cancer. Moreover, it also altered menstrual regularity in 34.8% and delayed on puberty development in 8.7% subjects.
- 21 July 2021
- Published by Springer Nature in Research Square
Open AccessAnti-Mullerian Hormone And Puberty Development On Girls And Adolescents Who Underwent Cancer Treatment
Background: High survival rate of children diagnosed with cancer has led to a growing population of women with premature ovarian failure (POF) due to chemotherapy and radiotherapy. The POF process occurs due to the disruption of the Hypothalamic-Pituitary and gonadal axis followed by the delay of puberty development. Evaluation of reproductive function in children with cancer is essential to determine the fertility preservation plan. This study aimed to describe reproductive function in children and adolescents with cancer who received chemotherapy based on Tanner stage evaluation, menstrual cycle, and Anti-Mullerian Hormone (AMH) examination using Electrochemilumiscence Immunoassay (ECLIA) Kit.Result: Twenty-three girls aged 12-18 years old and had menarche who underwent cancer therapy in January-August 2019 in Dr. Sardjito General Hospital were included in the study. Among them, 61% girls had low AMH levels and were defined as Diminished Ovarian Reserve (DOR). There were two subjects with DOR who experienced delayed puberty. Regular menstrual cycle was reported in 65.2% subjects, while 21.7% encountered secondary amenorrhea.Conclusion: Chemotherapy exposure impacted on DOR occurrence in 60.9% childhood and adolescence cancer. Moreover, it also altered menstrual regularity in 34.8% and delayed on puberty development in 8.7% subjects.
- Open Access
- 1 January 2021
- Published by Medknow in Journal of Human Reproductive Sciences
- Vol. 14 (1) , 81-86
Current awareness and attitude toward fertility preservation in Indonesia: A nationwide survey among health-care providers
Context: Fertility preservation (FP) is necessary for cancer patients who develop infertility due to chemotherapy and radiotherapy. In Indonesia, many systematic steps and long-term continued actions must be taken to establish FP units since there has been an increasing incidence of cancer among people under 45 years old. Aims: This study aimed at a comprehensive evaluation on the awareness and practices of health-care providers (HCPs) toward FP. Settings and Design: This was a descriptive cross-sectional study. Subjects and Methods: A validated nationwide online survey was completed by 160 HCPs as a representative sample from 11 provinces in 2017 that provide medical care to cancer patients at hospitals or clinics. Statistical Analysis Used: Descriptive statistics, analysis of variance, logistic regression, and Pearson correlation tests were used for the statistical analysis. Results: Respondents were specialists (59.4%) and other HCPs (40.6%). Around 60% of the HCPs who performed cancer therapies already discussed the fertility issues with their patients. Meanwhile, the HCPs (60.7%) also tended not to consult and refer their patients to fertility experts (P < 0.05). However, those who discussed the risk of infertility with patients tended to consult with and refer them to a fertility consultant for further FP procedure as the follow-up for their discussions (odds ratio = 8.98, confidence interval 95%, P < 0.05). Conclusions: In Indonesia, FP awareness of the HCPs who performed cancer therapy was high. Nevertheless, attitudes to refer patients to fertility experts for possible FP management still need to be improved.
- 1 January 2021
- Published by Medknow in Journal of Human Reproductive Sciences
- Vol. 14 (1) , 81-86
Open AccessCurrent awareness and attitude toward fertility preservation in Indonesia: A nationwide survey among health-care providers
Context: Fertility preservation (FP) is necessary for cancer patients who develop infertility due to chemotherapy and radiotherapy. In Indonesia, many systematic steps and long-term continued actions must be taken to establish FP units since there has been an increasing incidence of cancer among people under 45 years old. Aims: This study aimed at a comprehensive evaluation on the awareness and practices of health-care providers (HCPs) toward FP. Settings and Design: This was a descriptive cross-sectional study. Subjects and Methods: A validated nationwide online survey was completed by 160 HCPs as a representative sample from 11 provinces in 2017 that provide medical care to cancer patients at hospitals or clinics. Statistical Analysis Used: Descriptive statistics, analysis of variance, logistic regression, and Pearson correlation tests were used for the statistical analysis. Results: Respondents were specialists (59.4%) and other HCPs (40.6%). Around 60% of the HCPs who performed cancer therapies already discussed the fertility issues with their patients. Meanwhile, the HCPs (60.7%) also tended not to consult and refer their patients to fertility experts (P < 0.05). However, those who discussed the risk of infertility with patients tended to consult with and refer them to a fertility consultant for further FP procedure as the follow-up for their discussions (odds ratio = 8.98, confidence interval 95%, P < 0.05). Conclusions: In Indonesia, FP awareness of the HCPs who performed cancer therapy was high. Nevertheless, attitudes to refer patients to fertility experts for possible FP management still need to be improved.
- 1 September 2014
- Published by Elsevier in Fertility and Sterility
- Vol. 102 (3) , 864-870.e2
Novel dynamic culture system to support initiation of primordial follicle growth in prepubertal mouse ovaries
- 1 September 2014
- Published by Elsevier in Fertility and Sterility
- Vol. 102 (3) , 864-870.e2
Novel dynamic culture system to support initiation of primordial follicle growth in prepubertal mouse ovaries